-+ 0.00%
-+ 0.00%
-+ 0.00%

INVIVYD ANNOUNCES COMPLETION OF ENROLLMENT IN UPSIZED DECLARATION CLINICAL TRIAL, A PHASE 3 PIVOTAL STUDY OF VYD2311, AN INVESTIGATIONAL ANTIBODY TO PREVENT COVID

Reuters·06/01/2026 11:01:00

Please log in to view news